![Dallan Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dallan Murray
Corporate Officer/Principal presso
VOR BIOPHARMA INC.
Patrimonio netto: 567 682 $ in data 31/07/2026
Profilo
Dallan Murray is currently Chief Commercial Officer at Vor Biopharma, Inc. since 2025.
Formerly, Mr. Murray was Chief Customer Officer & Executive Vice President at Sarepta Therapeutics, Inc. from 2013 to 2025.
Education includes an MBA from Queen's University and an undergraduate degree from the University of Alberta.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2026 | 38.202 ( 0,04% ) | 567 682 $ | 31/07/2026 |
Posizioni attive di Dallan Murray
| Società | Posizione | Inizio |
|---|---|---|
| VOR BIOPHARMA INC. | Corporate Officer/Principal | 04/08/2025 |
Precedenti posizioni note di Dallan Murray
| Società | Posizione | Fine |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 16/07/2025 |
Formazione di Dallan Murray
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
